Published • loading... • Updated
Drugs Giant AstraZeneca Reveals Higher Profits, Savings Plan
Oncology drove the gain as revenue rose 7%, while a savings plan will cut costs and fund more than 180 drug projects.
Summary by Channels Television
8 Articles
8 Articles
AstraZeneca profit jumps 23% as it unveils major savings plan
AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.
·Lyon, France
Read Full Article
AstraZeneca reported an increase in revenue and profit in the third quarter, since the significant sales of oncological drugs compensated for the impact of patent expiration, boosting the group's turnover. Exclusive material for subscribers. To have full access, access the link of the subject and register.
·Rio de Janeiro, Brazil
Read Full Article
AstraZeneca has presented its results for the first nine months of 2026, period in which it has reached a total income of
Coverage Details
Total News Sources8
Leaning Left0Leaning Right1Center3Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
C 75%
R 25%
Factuality
To view factuality data please Upgrade to Premium
